Technical Aspects of Immunohistochemistry
Immunohistochemistry
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
Quantification of immunohistochemistry?issues concerning methods, utility and semiquantitative assessment II
Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patients
▪ Immunohistochemistry
Evaluation of Cell Proliferation in Rat Tissues with BrdU, PCNA, Ki-67(MIB-5) Immunohistochemistry and In Situ Hybridization for Histone mRNA
High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)